CLINICAL ROLE -
Updates to the American Diabetes Association Standards of Care in Diabetes
A notable revision now includes a dual GIP and GLP-1 receptor agonist (tirzepatide) as an additional option for glycemic management, preferred over insulin.
Read More
Beers Criteria Updates Refine, Introduce New Drug Criteria
This latest revision introduces a new set of drug criteria, refines the existing ones, and enhances the overall formatting to ensure increased ease of use and clarity for its recommendations.